Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AS1411
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Qualigen Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Qualigen Therapeutics Engages STA Pharmaceutical as GMP Manufacturer of AS1411 for Clinical Trials
Details : Qualigen Therapeutics has signed a contract with STA Pharmaceutical, a subsidiary of WuXi AppTec, for GMP production of AS1411, Qualigen's lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials.
Brand Name : AS1411
Molecule Type : Large molecule
Upfront Cash : Undisclosed
November 05, 2020
Lead Product(s) : AS1411
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Qualigen Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?